Numerous research, including large-scale studies [31], have consistently reported that tau levels (total tau and hyperphosphorylated tau) are prominently increased in the AD brain tissues [67,101], CSF [102], and plasma [85]. The gene discussed is MAPT; the disease is Alzheimer disease.